SCHEMBL1373385

SCHEMBL1373385

Brc1cccc2ccc3ccc4ccccc4c3c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.58
HSD17B10 Q99714 7/20 0.58
CYP1A2 P05177 6/20 0.58
HPGD P15428 5/20 0.58
THRB P10828 1/20 0.58
TSHR P16473 5/20 0.48
CYP2A6 P11509 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
ERBB2 P04626 1/20 0.47
FYN P06241 1/20 0.47
MAOA P21397 1/20 0.47
ACHE P22303 1/20 0.47
AHR P35869 1/20 0.47
HPRT1 P00492 1/20 0.44
CYP3A4 P08684 4/20 0.43
CYP1B1 Q16678 2/20 0.43
CYP1A1 P04798 1/20 0.43
POLB P06746 2/20 0.43
HIF1A Q16665 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30065106 1.00 ALDH1A1 (0.58) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL662611 0.93 ALDH1A1 (0.54) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL28357450 0.85 ALDH1A1 (0.59) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL29405571 0.85 ALDH1A1 (0.59) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL3420860 0.84 HSD17B10 (0.62) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL31108073 0.83 HSD17B10 (0.60) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL27105533 0.83 HSD17B10 (0.60) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL31541869 0.83 HSD17B10 (0.54) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL29613365 0.83 HSD17B10 (0.72) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL29487823 0.83 HSD17B10 (0.72) ALDH1A1HSD17B10CYP1A2HPGDTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115490659-B Nitrogen-containing compound, organic electroluminescent device and electronic device 陕西莱特光电材料股份有限公司 2023-09-12 CN disclosed
CN-115490659-A Nitrogen-containing compound, organic electroluminescent device, and electronic device 陕西莱特光电材料股份有限公司 2022-12-20 CN disclosed
US-9006503-B2 Organic electroluminescence devices containing substituted benzo[C]phenanthrenes MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-8710284-B2 Materials for organic electroluminescent devices containing substituted 10-benzo[c]phenanthrenes MERCK PATENT GMBH (DE) 2014-04-29 US disclosed
US-20140114076-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-04-24 US disclosed
US-20110288292-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
WO-2010083869-A2 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2010-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288292-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES DDT, DDC, BMI1 ALDH1A1 356/4885HSD17B10 1453/4885CYP1A2 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.